The effect of the use of fasica iliaca nerve blockade on patient positioning for spinal anaesthesia and the effect of continuous nerve blockade on post-operative pain and mobility outcomes in patients with hip fractures
Not Applicable
Completed
- Conditions
- Operative repair of fractured neck of femurSurgeryOperative repair of fracture
- Registration Number
- ISRCTN07083722
- Lead Sponsor
- Belfast Health and Social Care Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1. American Society of Anaesthesiologists (ASA) class I - IV
2. Patients able to give written informed consent
3. Patients requiring operative repair of fractured neck of femur
4. Patients aged 18 years and over, either sex
Exclusion Criteria
1. History of dementia or difficulty in obtaining consent
2. History of allergy to any of the medications used in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Part 1: Comparison of VAS score on rest and positioning for spinal anaesthesia in patients who have received either a fascia iliaca compartment block or convention sedation.<br>Part 2: Comparision between post-operative VAS scores in patients receiving fascia iliaca blockade with either lignocaine or levobupivacaine and the effect of bolus top-up doses of low dose levobupivacaine on VAS scores.
- Secondary Outcome Measures
Name Time Method 1. Length of time to first request of additional analgesia<br>2. The level of assistance required for transfer from the sitting to the standing position<br>3. Incidence and severity of motor blockade<br>4. Time taken to mobilisation with walking aid<br>5. Measurement of oxygen saturations without supplemental oxygen in both groups<br>6. Incidence of all complications associated with the analgesic techniques in both groups<br>7. Incidence of nausea and/or vomiting within the first 48 hours after surgery in both groups<br>8. Use of blood products in all groups